Acuta Capital Partners’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-511,500
| Closed | -$43.5M | – | 60 |
|
|
2020
Q3 | $43.5M | Sell |
511,500
-33,500
| -6% | -$1.69M | 11.81% | 1 |
|
|
2020
Q2 | $19.3M | Buy |
+545,000
| New | +$15.9M | 5.58% | 2 |
|
|
2020
Q1 | – | Sell |
-150,000
| Closed | -$3.17M | – | 46 |
|
|
2019
Q4 | $3.17M | Buy |
+150,000
| New | +$2.65M | 0.79% | 29 |
|
|
2019
Q3 | – | Sell |
-225,000
| Closed | -$3.12M | – | 38 |
|
|
2019
Q2 | $3.12M | Sell |
225,000
-275,000
| -55% | -$4.14M | 1.11% | 24 |
|
|
2019
Q1 | $9.61M | Buy |
500,000
+100,000
| +25% | +$1.61M | 4.57% | 7 |
|
|
2018
Q4 | $5.71M | Sell |
400,000
-1,655,500
| -81% | -$32.9M | 4.35% | 8 |
|
|
2018
Q3 | $42.8M | Sell |
2,055,500
-2,694,500
| -57% | -$63.8M | 15.27% | 1 |
|
|
2018
Q2 | $112M | Sell |
4,750,000
-1,100,000
| -19% | -$22.1M | 20.01% | 1 |
|
|
2018
Q1 | $85.5M | Sell |
5,850,000
-900,000
| -13% | -$14.7M | 13.96% | 1 |
|
|
2017
Q4 | $109M | Buy |
6,750,000
+12,294
| +0.2% | +$145K | 20.59% | 1 |
|
|
2017
Q3 | $94.2M | Buy |
6,737,706
+5,137,706
| +321% | +$51.2M | 16.88% | 1 |
|
|
2017
Q2 | $14.1M | Buy |
1,600,000
+1,097,000
| +218% | +$7.7M | 3.95% | 9 |
|
|
2017
Q1 | $3.25M | Sell |
503,000
-4,197,000
| -89% | -$21.3M | 0.77% | 34 |
|
|
2016
Q4 | $17.2M | Buy |
4,700,000
+850,000
| +22% | +$2.51M | 6.41% | 4 |
|
|
2016
Q3 | $12.5M | Sell |
3,850,000
-350,000
| -8% | -$979K | 4.7% | 4 |
|
|
2016
Q2 | $9.74M | Sell |
4,200,000
-1,326,172
| -24% | -$4.43M | 4.68% | 5 |
|
|
2016
Q1 | $13.8M | Buy |
5,526,172
+1,562,139
| +39% | +$3.51M | 7.73% | 3 |
|
|
2015
Q4 | $12.2M | Buy |
3,964,033
+2,252,966
| +132% | +$6.29M | 5.82% | 5 |
|
|
2015
Q3 | $2.94M | Buy |
+1,711,067
| New | +$4.37M | 1.7% | 23 |
|
Acuta Capital Partners's IMMU Position: Q4 2020 in Review
Acuta Capital Partners sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 511,500 shares — an estimated $43.5M sold.
Acuta Capital Partners first reported a position in IMMU in Q3 2015 and held it in 19 quarters. The position peaked at $112M in Q2 2018. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Acuta Capital Partners reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Acuta Capital Partners sold 511,500 Immunomedics Inc shares in Q4 2020, an estimated $43.5M.
- Acuta Capital Partners first reported a position in Immunomedics Inc in Q3 2015 and held it in 19 quarters.
- Acuta Capital Partners's Immunomedics Inc position peaked at $112M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Acuta Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.